92 related articles for article (PubMed ID: 11705002)
1. Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report.
Gezer E; Selek A; Tarkun İ; Cantürk Z; Çetinarslan B
J Med Case Rep; 2019 Apr; 13(1):95. PubMed ID: 31003598
[TBL] [Abstract][Full Text] [Related]
2. Papillary thyroid carcinoma with lung metastasis arising from dyshormonogenetic goiter: a case report.
Erden ES; Babayigit C; Davran R; Akin M; Karazincir S; Isaogullari N; Demirkose M; Genc S
Case Rep Med; 2013; 2013():813167. PubMed ID: 24307906
[TBL] [Abstract][Full Text] [Related]
3. Spinal metastasis in thyroid cancer.
Ramadan S; Ugas MA; Berwick RJ; Notay M; Cho H; Jerjes W; Giannoudis PV
Head Neck Oncol; 2012 Jun; 4():39. PubMed ID: 22730910
[TBL] [Abstract][Full Text] [Related]
4. Challenging cases in thyroid cancer: a multidisciplinary approach.
Tuttle M; Robbins R; Larson SM; Strauss HW
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):605-12. PubMed ID: 14666383
[TBL] [Abstract][Full Text] [Related]
5. [Differentiated thyroid carcinoma: initial evaluation and follow-up].
Golbert L; Wajner SM; Rocha AP; Maia AL; Gross JL
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):701-10. PubMed ID: 16444352
[TBL] [Abstract][Full Text] [Related]
6. The management of metastatic differentiated thyroid carcinoma.
Sherman SI
Rev Endocr Metab Disord; 2000 Apr; 1(3):165-71. PubMed ID: 11705002
[No Abstract] [Full Text] [Related]
7. [Diagnosis and treatment of differentiated thyroid carcinoma].
Mora J
Rev Esp Med Nucl; 2003; 22(5):349-59; quiz 360-2. PubMed ID: 14534014
[No Abstract] [Full Text] [Related]
8. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
Franceschi M; Kusić Z; Franceschi D; Lukinac L; Roncević S
J Nucl Med; 1996 Mar; 37(3):446-51. PubMed ID: 8772642
[TBL] [Abstract][Full Text] [Related]
11. [Controversies in the follow-up and management of well-differentiated thyroid cancer. New answers to old questions].
Abós Olivares MD; Pesquera González C
Rev Esp Med Nucl; 2005; 24(3):207-15. PubMed ID: 15847791
[No Abstract] [Full Text] [Related]
12. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status.
Venkataraman GM; Yatin M; Marcinek R; Ain KB
J Clin Endocrinol Metab; 1999 Jul; 84(7):2449-57. PubMed ID: 10404820
[TBL] [Abstract][Full Text] [Related]
13. [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.
Wang W; Macapinlac H; Larson SM; Yeh SD; Akhurst T; Finn RD; Rosai J; Robbins RJ
J Clin Endocrinol Metab; 1999 Jul; 84(7):2291-302. PubMed ID: 10404792
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
